share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities- PFIZER INC

Pfizer | 4: Statement of changes in beneficial ownership of securities- PFIZER INC

輝瑞 | 4:持股變動聲明- PFIZER INC
美股SEC公告 ·  08/05 18:27
Moomoo AI 已提取核心訊息
Pfizer Inc, formerly a 10% owner of Cerevel Therapeutics Holdings, Inc. [CERE], completed a significant transaction by selling all of its holdings in the company. The sale consisted of 27,349,211 shares of common stock on August 1, 2024, at a price of $45.00 per share. This transaction resulted in a total market value of $1,230,714,495. Following this transaction, Pfizer Inc no longer holds any shares in Cerevel Therapeutics. The sale marks the end of Pfizer's direct ownership stake in the company.
Pfizer Inc, formerly a 10% owner of Cerevel Therapeutics Holdings, Inc. [CERE], completed a significant transaction by selling all of its holdings in the company. The sale consisted of 27,349,211 shares of common stock on August 1, 2024, at a price of $45.00 per share. This transaction resulted in a total market value of $1,230,714,495. Following this transaction, Pfizer Inc no longer holds any shares in Cerevel Therapeutics. The sale marks the end of Pfizer's direct ownership stake in the company.
輝瑞公司(Pfizer Inc)曾是Cerevel Therapeutics Holdings Inc [CERE]的10%股東,通過出售該公司的所有持股來完成了一項重大交易。該出售包括在2024年8月1日以45.00美元的價格出售了27,349,211股普通股。此交易導致總市值爲1,230,714,495美元。在此交易後,輝瑞公司不再持有Cerevel Therapeutics的任何股份。這次出售標誌着輝瑞公司對該公司的直接所有權份額的結束。
輝瑞公司(Pfizer Inc)曾是Cerevel Therapeutics Holdings Inc [CERE]的10%股東,通過出售該公司的所有持股來完成了一項重大交易。該出售包括在2024年8月1日以45.00美元的價格出售了27,349,211股普通股。此交易導致總市值爲1,230,714,495美元。在此交易後,輝瑞公司不再持有Cerevel Therapeutics的任何股份。這次出售標誌着輝瑞公司對該公司的直接所有權份額的結束。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息